Close
Nordic 9Nordic 9

Lifespan Vision Ventures (investor - Venture Capital)

United States lifespanvisionventures.com
See something wrong or missing? Let us know
Offices:Boston
Average round investment:8.78M USD
Average number per year:1.5
Distribution: 2024 (2)2022 (1)
Portfolio companies: United Kingdom LIfT BioSciencesUnited Kingdom Senisca
Mostly invests in: United Kingdom United Kingdom (3) Biotech (3)

3 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Lifespan Vision Ventures

Name Criteria
United States Lombardstreet Ventures
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Manufacturing, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United Kingdom Milltrust Ventures
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Manufacturing, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United Kingdom SCVC
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Manufacturing, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United Kingdom Sussex Place Ventures
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Manufacturing, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
Singapore Vulpes Investment Management
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Manufacturing, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United Kingdom Oxford Seed Fund
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Manufacturing, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United Kingdom Norcliffe Capital
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Manufacturing, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Belgium Syensqo Ventures
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Manufacturing, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Italy Alchimia Investments
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Manufacturing, Health services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Switzerland infinitas capital group
83%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Manufacturing, Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Top